PanitiSukumvanichMD
Obstetrics & Gynecology • Pittsburgh, PAGeneral Gynecology, Gynecologic Oncology
Associate Professor, Ob/Gyn & Reproductive Science, University of Pittsburgh School of Medicine
Dr. Sukumvanich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Halket St
Ste 0610
Pittsburgh, PA 15213Phone+1 412-641-4200
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gynecologic Oncology, 2001 - 2004
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1997 - 2001
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1997
Certifications & Licensure
PA State Medical License 1998 - 2024
NY State Medical License 2001 - 2007- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- Association of neighborhood social vulnerability with ovarian cancer survival.Lauren Borho, Esther Elishaev, Riyue Bao, Emily O'Brien, Kaitlyn Dinkins
Gynecologic Oncology. 2024-11-21 - Lymph node dissection after neoadjuvant chemotherapy improves overall survival in clinical stage III endometrial cancer.Megan E Lander, John A Vargo, Ronald Buckanovich, Alison Garrett, Parul Barry
International Journal of Gynecological Cancer. 2024-11-04 - 1 citationsConcurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne
Clinical Cancer Research. 2024-08-15
Journal Articles
- Survival Advantage Associated with Multimodal Therapy in Women with Node‐Positive (Stage‐IIIC) Uterine Papillary Serous Carcinoma: A National Cancer Database StudyJ F Lin, K Muniz, P Gehrig, R P Edwards, A B Olawaiye, S Beriwal, P Sukumvanich, J L Kelley, BJOG: An International Journal of Obstetrics & Gynaecology
Press Mentions
The Toughest 9 Months: Pregnant with CancerMarch 2nd, 2016
The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
